Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials.
Saved in:
| Title: | Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials. |
|---|---|
| Authors: | Qi, Litong1 (AUTHOR), Shen, Hua2 (AUTHOR), Chai, Meng2 (AUTHOR), Chen, Beijian3 (AUTHOR), He, Yongming4 (AUTHOR), Shi, Xiaoxia5 (AUTHOR), Lian, Qiufang6 (AUTHOR), Zhao, Wang7 (AUTHOR), Qu, Yanling8 (AUTHOR), Qian, Lei9 (AUTHOR), Zhang, Jianwei9 (AUTHOR), Li, Haoyu9 (AUTHOR), Zhou, Yujie2 (AUTHOR) azzyj12@163.com, Huo, Yong1 (AUTHOR) huoyong2632@163.com |
| Source: | Cardiovascular Diabetology. 7/3/2025, Vol. 24 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
